Search

Search Results
Results 4101 - 4110 of 5284 for Active site
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Ketalar intended for persons living in Australia.
  • News - 3 Sep 2024
    The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) has awarded grants for 10 projects to improve diagnostic tools for congenital and adult syphilis -...
  • Drug - 8 Aug 2024
    Consumer Medicine Information (CMI) about Ovidrel Syringe intended for persons living in Australia.
  • Drug - 4 Jul 2024
    Consumer Medicine Information (CMI) about Sandostatin LAR (2.0 mL diluent) intended for persons living in Australia.
  • News - 24 Jun 2024
    This interview examines the principles of continuous improvement and how they can be applied to enhance QMS.
  • Drug - 31 May 2024
    Consumer Medicine Information (CMI) about Austrapen intended for persons living in Australia.
  • Drug - 29 May 2024
    Consumer Medicine Information (CMI) about Spevigo intended for persons living in Australia.
  • News - 30 Apr 2024
    For many years, Rose Sims had no idea what was going on inside a nondescript brick building on Florida Street a couple of miles from her modest one-story home on the southwestern side of town.
  • Drug - 26 Apr 2024
    Consumer Medicine Information (CMI) about Viramune intended for persons living in Australia.
  • Drug - 4 Apr 2024
    Consumer Medicine Information (CMI) about Vyalev intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.